ARS Pharmaceuticals Stock (NASDAQ: SPRY) stock price, news, charts, stock research, profile.
You can purchase shares of ARS Pharmaceuticals (NASDAQ:SPRY) through any online brokerage.
Other companies in ARS Pharmaceuticals’s space includes: Gyre Therapeutics (NASDAQ:GYRE), Upstream Bio (NASDAQ:UPB), Arcutis Biotherapeutics (NASDAQ:ARQT), Day One Biopharmaceutical (NASDAQ:DAWN) and CareDx (NASDAQ:CDNA).
ARS Pharmaceuticals has a consensus price target of $22.00.
The stock price for ARS Pharmaceuticals (NASDAQ: SPRY) is $17.0399 last updated November 8, 2024 at 7:35 PM EST.
There are no upcoming dividends for ARS Pharmaceuticals.
ARS Pharmaceuticals’s Q3 earnings are confirmed for Friday, November 22, 2024.
There is no upcoming split for ARS Pharmaceuticals.
ARS Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.